HomeCompareNNRHF vs JNJ

NNRHF vs JNJ: Dividend Comparison 2026

NNRHF yields 9.86% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NNRHF wins by $18.4K in total portfolio value
10 years
NNRHF
NNRHF
● Live price
9.86%
Share price
$16.01
Annual div
$1.58
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$38.4K
Annual income
$1,831.66
Full NNRHF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — NNRHF vs JNJ

📍 NNRHF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNNRHFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NNRHF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NNRHF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NNRHF
Annual income on $10K today (after 15% tax)
$837.79/yr
After 10yr DRIP, annual income (after tax)
$1,556.91/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, NNRHF beats the other by $853.30/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NNRHF + JNJ for your $10,000?

NNRHF: 50%JNJ: 50%
100% JNJ50/50100% NNRHF
Portfolio after 10yr
$29.2K
Annual income
$1,329.72/yr
Blended yield
4.55%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

NNRHF
No analyst data
Altman Z
1.3
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NNRHF buys
0
JNJ buys
0
No recent congressional trades found for NNRHF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNNRHFJNJ
Forward yield9.86%3.36%
Annual dividend / share$1.58$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$38.4K$20.0K
Annual income after 10y$1,831.66$827.78
Total dividends collected$14.1K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NNRHF vs JNJ ($10,000, DRIP)

YearNNRHF PortfolioNNRHF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,686$985.64$10,676$355.77+$1.0KNNRHF
2$13,580$1,076.43$11,407$389.39+$2.2KNNRHF
3$15,700$1,169.10$12,198$426.53+$3.5KNNRHF
4$18,062$1,263.17$13,056$467.62+$5.0KNNRHF
5$20,684$1,358.15$13,987$513.12+$6.7KNNRHF
6$23,586$1,453.59$14,998$563.56+$8.6KNNRHF
7$26,786$1,549.06$16,098$619.52+$10.7KNNRHF
8$30,305$1,644.14$17,295$681.69+$13.0KNNRHF
9$34,165$1,738.46$18,599$750.82+$15.6KNNRHF
10$38,388$1,831.66$20,022$827.78+$18.4KNNRHF

NNRHF vs JNJ: Complete Analysis 2026

NNRHFStock

Neinor Homes, S.A., together with its subsidiaries, develops, promotes, rental, and manages real estate properties in Spain. The company operates through Legacy, Development, Assets Management-Servicing, and Rental segments. Its land portfolio consists of 160 lots with a total of 9.700 buildable units in Madrid, Catalonia, the Basque Country, Valencia, and Andalusia. Neinor Homes, S.A. was founded in 1988 and is headquartered in Bilbao, Spain.

Full NNRHF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this NNRHF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NNRHF vs SCHDNNRHF vs JEPINNRHF vs ONNRHF vs KONNRHF vs MAINNNRHF vs ABBVNNRHF vs MRKNNRHF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.